New Study : Hepatitis Drugs Could Serve as Coronavirus Treatment

Two hepatitis C (HCV) antiviral drugs were found to raise survival rates for people with moderate or severe COVID-19 according to a series of Iranian studies reported at the online International AIDS Conference last week.

Study co-author Andrew Hill, MD, of Liverpool University said the antiviral drugs sofosbuvir and daclatasvir could offer an affordable and widely accessible treatment option, according to early study findings.